GlassScriptPhysician profile
Marloe Prince
NPI 1740696343
$61,355.84
in general payments reported to CMS, 2019-2025
42 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,067 · 2020: $1,500 · 2021: $4,906 · 2022: $3,284 · 2023: $2,866 · 2024: $23K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Travel and Lodging: $10K · Consulting Fee: $9,960 · Honoraria: $7,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,773.29 |
| Travel and Lodging | $10,185.13 |
| Consulting Fee | $9,960.00 |
| Honoraria | $7,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,880.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $23,676.91 | 2019-2025 | Impella, Spotlight |
| Medtronic, INC. | $6,875.31 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Angiodynamics, INC. | $5,743.16 | 2021-2025 | Alphavac, Auryon Laser System 100-120 Vac, Angiovac |
| Recor Medical INC | $5,315.60 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Siemens Medical Solutions USA, INC. | $4,244.13 | 2023-2025 | Acuson Origin Diagnostic Ultrasound System, Acuson Sc2000 Diagnostic Ultrasound System |
| Boston Scientific Corporation | $2,889.22 | 2019-2025 | Watchman Flx, Varithena Administration Pack, Watchman Access System |
| Abbott Laboratories | $2,123.12 | 2020-2025 | Jot Dx, Cardiomems, Diamondback Peripheral |
| Penumbra, INC. | $1,881.93 | 2021-2023 | Indigo System |
| Edwards Lifesciences Corporation | $1,765.29 | 2021-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $688.82 | 2021-2023 | Xarelto |
| Endologix LLC | $585.39 | 2025 | Endocross Device, Torus Stent Graft System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $552.88 | 2021-2025 | Lifevest |
| Pfizer INC. | $466.37 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $457.44 | 2019-2024 | Rotarexs 6 F X 135 Cm |
| Astrazeneca Pharmaceuticals LP | $416.85 | 2019-2025 | Wainua |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $389.86 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Lantheus Medical Imaging, INC. | $367.05 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $311.49 | 2022-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $287.70 | 2020 | |
| W. L. Gore & Associates, INC. | $279.72 | 2021 | |
| Shockwave Medical, INC | $224.84 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $222.55 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $207.25 | 2021-2025 | Cobenfy, Camzyos |
| Amgen INC. | $192.57 | 2021-2025 | Repatha, Repatha |
| Surmodics, INC. | $163.82 | 2023 | Sublime Radial Access Guide Sheath, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Novartis Pharmaceuticals Corporation | $155.77 | 2021-2025 | |
| Philips North America LLC | $131.97 | 2023-2024 | (Az7) Lasers |
| Kestra Medical Technology Services, INC. | $118.58 | 2024 | Assure Wcd |
| Imperative Care, INC | $115.61 | 2025 | Symphony Catheter |
| Inspire Medical Systems, INC. | $71.75 | 2024 | Inspire |
| Tactile Systems Technology INC | $66.69 | 2024 | Entre Plus, Flexitouch Plus |
| Livanova USA, INC. | $63.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $53.60 | 2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $49.33 | 2020-2021 | |
| Bolton Medical INC | $43.74 | 2023-2025 | Treo Abdominal Stent-Graft System |
| Biosense Webster, INC. | $41.62 | 2025 | Nuvision Ice Catheter |
| Cordis US Corp. | $32.84 | 2024 | Mynx Control, Mynx Venous Vcd |
| Mallinckrodt Enterprises LLC | $19.98 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2025 | |
| Stryker Corporation | $15.36 | 2025 | Limflow System |
| Chiesi USA, INC. | $13.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marloe Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.